Holding(s) in Company

Phytopharm PLC 11 June 2007 TR-1: notification of major interests in shares 1. Identity of the issuer or Phytopharm plc the underlying issuer of -------------------- existing shares to which voting rights are attached: ------------------------------- 2. Reason for the notification (please tick the appropriate box or boxes) -------------------------------------------- ------- An acquisition or disposal of voting rights (X) An acquisition or disposal of financial instruments which may result in the ( ) acquisition of shares already issued to which voting rights are attached ------- -------------------------------------------- An event changing the breakdown of voting rights ( ) -------------------------------------------- ------- Other (please specify):___________________________________________ ( ) -------------------------------------------- ------- 3. Full name of person(s) AXA S.a, 25 Avenue Matignon, 75008 Paris and its group of companies subject to the notification -------------------- obligation: ------------------------------- 4. Full name of shareholder(s) (if different from 3.): -------------------- ------------------------------- 5. Date of the transaction (and 07/06/2007 date on which the threshold is -------------------- crossed or reached if different) ------------------------------- 6. Date on which issuer 08/06/2007 notified: -------------------- ------------------------------- 7. Threshold(s) that is/are crossed or reached: -------------------- ------------------------------- 8. Notified details: ------------------------------- -------------------- A: Voting rights attached to shares Class/type Situation previous to the Resulting situation after the triggering of shares Triggering transaction transaction if possible using the Number of Number of Number of Number of voting % of voting ISIN CODE Shares Voting shares rights rights Rights Direct Direct x Indirect xi Direct Indirect Ordinary 1 Pence 3,328,148 3,328,148 11,000 11,000 3,327,148 0.02 5.98 GB000686972 B: Financial Instruments Resulting situation after the triggering transaction Type of Expiration Exercise/ Number of voting rights that may % of financial date Conversion be acquired if the instrument is voting instrument Period/ Date exercised/ converted. rights Total (A+B) Number of voting rights % of voting rights 3,338,148 6.00% 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: Name of the Company/Fund Number of Shares % of issued share capital AXA UK Investment Co ICVC UK Smaller Companies Fund 620 0.00111 Indirect Sun Life Pensions Management Ltd 11,000 0.01978 Direct AXA Framlington Equity Income 1,851,612 3.32986 Indirect AXA Framlington Biotech 1,052,631 1.89301 Indirect Framlington onshore private clients 396,483 0.71302 Indirect Framlington onshore private clients 25,802 0.04640 Indirect Total direct 11,000 0.01978 Total Indirect 3,327,148 5.98340 Total 3,338,148 6.00318 Proxy Voting: 10. Name of the proxy holder: 11. Number of voting rights proxy holder will cease to hold: 12. Date on which proxy holder will cease to hold voting rights: 13. Additional Notification using the total voting rights figure of information: 55,606,309 14. Contact name: Zoe McGowan, Company Secretary 15. Contact telephone number: 01480 437697 This information is provided by RNS The company news service from the London Stock Exchange

Companies

Ixico (IXI)
UK 100

Latest directors dealings